TP53 and Miyoshi myopathy: Although TP53 mutations/deletions are rare occurrences (~10%) in newly diagnosed MM [13,14,15,16], TP53 inactivation is an adverse risk factor in MM due to its association with resistance to standard therapy and poor prognosis.